Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

NCT01019798 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: sunitinib, docetaxel, cisplatin

Sponsor

Taipei Medical University Hospital

Collaborators

[object Object]
[object Object]